Wilson Wu

Wilson Wu has extensive experience in the field of biometrics and biostatistics. Wilson is currently employed as the Senior Vice President of Biometrics at Arcus Biosciences since February 2023. Prior to that, they held the same position at Turning Point Therapeutics from November 2020 to February 2023. Before that, they worked as the Senior Vice President of Biometrics at Denovo Biopharma from January 2020 to November 2020. Wilson has also worked as the Vice President of Biometrics at Halozyme Therapeutics, Inc. from September 2013 to December 2019. Their earlier experience includes serving as the Biostatistics Head for Infectious Diseases and Vaccines at AstraZeneca from November 2008 to August 2013, and as the Director of Biostatistics at Pfizer from May 2003 to October 2008. Wilson started their career as a Biostatistician at Westat from January 2001 to April 2003.

Wilson Wu has a Master of Science (MS) degree in Statistics from Texas A&M University and a Doctor of Philosophy (PhD) degree in Biostatistics from The University of Texas Health Science Center at Houston (UTHealth Houston).